EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 3.0

Drug repurposing of fluoroquinolones as anticancer agents in 2023

Asmaa E Kassab iD, Rania M Gomaa, Ehab M Gedawy

RSC Advances · 2024 · 14 (50) · 37114-37130

DOI: 10.1039/d4ra03571b ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift RSC Advances, 2024. Verfasst von Asmaa E Kassab und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Organic Chemistry, Faculty of Pharmacy, Cairo University Kasr El-Aini Street, P. O. Box 11562 Cairo Egypt. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Drug developers are currently focusing on investigating alternative strategies, such as “drug repositioning”, to address issues associated with productivity, regulatory obstacles, and the steadily rising cost of pharmaceuticals.

Autor:innen und Institutionen

  • Department of Pharmaceutical Organic Chemistry, Faculty of Pharmacy, Cairo University Kasr El-Aini Street, P. O. Box 11562 Cairo Egypt.
  • Department of Pharmaceutical Organic Chemistry, Faculty of Pharmacy, Mansoura University P. O. Box 35516 Mansoura Egypt.
  • Department of Pharmaceutical Chemistry, Faculty of Pharmacy and Pharmaceutical Industries, Badr University in Cairo (BUC) Badr City, P. O. Box 11829 Cairo Egypt asmaa.kassab@pharma.cu.edu.eg +2023635140 +2023639307.

ORCID-Profile: Asmaa E Kassab

Zitieren

APA

Kassab, A. E., Gomaa, R. M., & Gedawy, E. M. (2024). Drug repurposing of fluoroquinolones as anticancer agents in 2023. RSC Advances, 14(50), 37114-37130. https://doi.org/10.1039/d4ra03571b

Vancouver

Kassab AE, Gomaa RM, Gedawy EM. Drug repurposing of fluoroquinolones as anticancer agents in 2023. RSC Advances. 2024;14(50):37114-37130. doi:10.1039/d4ra03571b

BibTeX
@article{Kassab2024,
  author = {Kassab, Asmaa E and Gomaa, Rania M and Gedawy, Ehab M},
  title = {Drug repurposing of fluoroquinolones as anticancer agents in 2023},
  journal = {RSC Advances},
  year = {2024},
  volume = {14},
  number = {50},
  pages = {37114--37130},
  doi = {10.1039/d4ra03571b}
}
Kostenlos starten →